Insider: Cline Christopher R. CHIEF FINANCIAL OFFICER - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 111,226 | 0 | 111,226 |
| Value | $3,385,719.44 | $0.00 | $3,385,719.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/04/2026 | DDS | 110 | Direct | COM | $32.90 | $3,619.00 | 111,226 |
| 02/04/2026 | DDS | 1,635 | Direct | COM | $32.14 | $52,548.90 | 111,336 |
| 02/03/2026 | DDS | 7,242 | Direct | COM | $32.12 | $232,613.04 | 112,971 |
| 12/01/2025 | DDS | 20,000 | Direct | COM | $35.01 | $700,202.00 | 92,083 |
| 09/04/2025 | DDS | 119 | Direct | COM | $19.71 | $2,345.49 | 92,083 |
| 09/03/2025 | DDS | 454 | Direct | COM | $18.20 | $8,262.80 | 92,202 |
| 08/27/2025 | DDS | 470 | Direct | COM | $17.31 | $8,135.70 | 92,656 |
| 05/05/2025 | DDS | 1,784 | Direct | COM | $21.05 | $37,553.20 | 93,126 |
| 04/11/2025 | DDS | 48 | Direct | COM | $13.14 | $630.94 | 89,990 |
| 02/03/2025 | DDS | 5,192 | Direct | COM | $20.12 | $104,463.04 | 90,038 |
| 01/22/2025 | DDS | 865 | Direct | COM | $18.94 | $16,383.88 | 73,730 |
| 09/09/2024 | DDS | 2,490 | Direct | COM | $11.52 | $28,684.80 | 74,595 |
| 09/04/2024 | DDS | 514 | Direct | COM | $9.51 | $4,887.78 | 70,335 |
| 04/11/2024 | DDS | 54 | Direct | COM | $6.74 | $363.96 | 70,849 |
| 02/01/2024 | DDS | 3,818 | Direct | COM | $8.53 | $32,572.50 | 70,903 |
| 01/23/2024 | DDS | 853 | Direct | COM | $9.07 | $7,735.35 | 49,721 |
| 09/05/2023 | DDS | 457 | Direct | COM | $14.71 | $6,722.56 | 50,574 |
| 05/10/2023 | DDS | 455 | Direct | COM | $16.59 | $7,548.45 | 51,031 |
| 04/11/2023 | DDS | 47 | Direct | COM | $21.49 | $1,010.03 | 51,486 |
| 02/01/2023 | DDS | 1,588 | Direct | COM | $21.75 | $34,542.18 | 51,533 |
| 01/24/2023 | DDS | 852 | Direct | COM | $21.90 | $18,662.55 | 32,871 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research